S
Shape Memory Medical
Biotech & Life Sciences · Santa Clara, United States · Founded 2009
Innovative medical devices based on shape memory polymer (smp) materials MoreLess
Shape Memory Medical specializes in developing advanced embolization devices for neurovascular and peripheral vascular procedures. The company's flagship products, the IMPEDE and IMPEDE FX Embolization Plugs, and the TrelliX Embolic Coil, utilize cutting-edge shape memory polymer technology to provide superior performance in vascular embolization. These devices are designed to block blood flow in targeted vessels, aiding in the treatment of various medical conditions such as aneurysms and arteriovenous malformations. Shape Memory Medical serves healthcare providers and physicians globally, operating in the medical device market with a focus on innovation and patient outcomes. The business model is based on the sale and distribution of its proprietary medical devices, generating revenue through direct sales and partnerships with local distributors. The company holds CE marks for its products, allowing for commercial availability in multiple countries.
Keywords: embolization, neurovascular, peripheral vascular, shape memory polymer, IMPEDE, TrelliX, medical devices, healthcare, innovation, CE mark.
Company overview
Shape Memory Medical company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2009
- Headquarters
- Santa Clara, United States
- Employees
- 47
- Open positions
- None listed
- Dealroom signal
- 70.9
Valuation & funding
Shape Memory Medical funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Mar 2024 | $38M | $152M | Wexford Capital · HBM Healthcare Investments · Earlybird Venture Capital · Emergent Medical Partners | ↗ |
| CONVERTIBLEOther financing | Apr 2023 | $600K | — | HBM Partners | — |
| CONVERTIBLEOther financing | Jul 2022 | $0 | — | HBM Healthcare Investments | — |
| CONVERTIBLEOther financing | Mar 2021 | $0 | — | HBM Healthcare Investments | — |
| SERIES BOther financing | May 2020 | $1.4M | $5.6M | Undisclosed | — |
| SERIES BOther financing | Jul 2017 | Wexford Capital · HBM Healthcare Investments · Emergent Medical Partners | — | ||
| CONVERTIBLEOther financing | Apr 2016 | Undisclosed | — | ||
| SEEDOther financing | Jan 2015 | Undisclosed | — | ||
| GRANTOther financing | Mar 2014 | MedTech Innovator | — | ||
| SPINOUTOther financing | Jan 2009 | Texas A&M University · Lawrence Livermore National Laboratory | — |
Growth signals
Shape Memory Medical website traffic
Latest recorded traffic for Shape Memory Medical is 1.9K monthly website visits, up 0% over the last three months. Shape Memory Medical's team grew 0% over the past year.
Hiring
Open positions at Shape Memory Medical
Current openings linked to this company in Dealroom.
Comparisons
Shape Memory Medical compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
 GelmetixInjectable polymer gel for non-surgical chronic pain treatment |
London, United Kingdom | Operational | 9 | $30M | $26M |
 Acs BiotechDeveloping an innovative injectable cartilage repair solution to treat osteoarthritis |
Villeurbanne, France | Operational | |||
 Z FactorTherapeutic agents for alpha-1-antitrypsin deficiency treatment |
Babraham, United Kingdom | Acquired | |||
 MIP DiagnosticsDevelops “plastic antibodies” for a variety of applications |
Bedford, United Kingdom | Operational | |||
 ShenandoahDevelopment of oncology treatment technologies |
Siloam Springs, United States | Operational | |||
 BiotomeDeveloping high-precision antibody diagnostics |
City of Nedlands, Australia | Operational | |||
 AlphaTauAlpha Tau Medical focuses on research, development and commercialization of Alpha DaRT for the treatment of solid cancer tumors |
Jerusalem, Israel | Operational | |||
 AntegenesGenetic tests for personalized cancer risk prevention |
Tartu, Estonia | Operational |
Talent graph
Shape Memory Medical's talent
Source: Dealroom Talent Intelligence.
Investors
9 investors on Shape Memory Medical's cap table
Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.
Global footprint
Where Shape Memory Medical has talent and traffic
team presence
In the news
Latest news about Shape Memory Medical
Recent press, funding announcements, and product moves mentioning Shape Memory Medical — open to read from the original sources.
Market sentiment
What the market is saying about Shape Memory Medical
An AI-synthesized read of the highest-engagement posts about Shape Memory Medical on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Shape Memory Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.